Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonlicromanol in children with mitochondrial disease
NCT04846036Phase 2Suspended
- Sponsor
- Khondrion
- Start
- Feb 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sonlicromanol in mitochondrial disease, mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), Leigh syndrome, subacute necrotizing encephalomyelopathy (SNE), sponsored by Khondrion. Started Feb 2021; status: suspended.
02
Drugs
sonlicromanol
03
Conditions
mitochondrial diseasemitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)Leigh syndromesubacute necrotizing encephalomyelopathy (SNE)
Beyond the preview
Go deeper on NCT04846036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04846036.